New hope for seniors: gentler treatment aims to keep breast cancer at bay
NCT ID NCT03587740
Summary
This study is testing a drug called T-DM1 to see if it can help prevent a specific type of breast cancer (HER2-positive) from returning after surgery in patients aged 60 and older. The drug is designed to target cancer cells directly, which may lead to fewer side effects compared to standard chemotherapy. Researchers want to see if this approach is safe and effective for long-term disease control in this older population.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Comprehensive Cancer Center
Duarte, California, 91010, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Dana-Farber Cancer Institute at St. Elizabeth's Medical Center
Brighton, Massachusetts, 02135, United States
-
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
Milford, Massachusetts, 01757, United States
-
Dana-Farber/Brigham and Women's Cancer Center in clinical affiliation with South Shore Hospital
South Weymouth, Massachusetts, 02190, United States
-
Dana-Farber/New Hampshire Oncology-Hematology
Londonderry, New Hampshire, 03053, United States
-
Lifespan Cancer Institute
Providence, Rhode Island, 02903, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02215, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Rex Cancer Center
Raleigh, North Carolina, 27607, United States
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
The Stamford Hospital
Stamford, Connecticut, 06904, United States
-
University of North Carolina
Chapel Hill, North Carolina, 27599, United States
Conditions
Explore the condition pages connected to this study.